Watanabe K, Matsui M, Matsuzawa J, Tanaka C, Noguchi K, Yoshimura N, Hongo K, Ishiguro M, Wanatabe S, Hirono K, Uese K, Ichida F, Origasa H, Nakazawa J, OshimaY, Miyawaki T, Yagihara T, Bilker W, Gur RC: Impaired neuroanatomical development in Infants with Congenital Heart Disease. Journal of Thoracic and Cardiovascular Surgery, 137 (1), 146-153, 2009.
Sumiyoshi T, Higuchi Y, Itoh T, Matsui M, Arai H, Suzuki M, Kurachi M, Sumiyoshi C, Kawasaki Y: Effect of perospirone on P300 electrophysiological activity in schizophrenia: A three-dimensional analysis with sLORETA, Psychiatry Research: Neuroimaging,172 (3), 180-183, 2009.
Matsui M, Arai H, Yonezawa M, Sumiyoshi T, Suzuki M, Kurachi M: The effects of cognitive rehabilitation on social knowledge in patients with schizophrenia. Applied Neuropsychology, 16 (3), 158-164, 2009.
Matsuzaki T, Matsui M, Ichida F, Nakazawa J, Hattori A, Yoshikoshi K, Miyazaki M, Fujii M, Hagino I, Yagihara T: Neurodevelopment in 1-year-old Japanese infants after congenital heart surgery. Pediatrics International, 53(2), in press.
Nguyen B.D., Nguyen H.M., Hoang L.V., Matsui M., Nishijo H., Ono T., Tran A.H.: Investigation on changes of hippocampal volumes in Alzheimer’s disease patients. Vietnam Journal of Physiology, 13, 1-10, 2009.
Matsui M, Suzuki M, Zhou SY, Takahashi T, Kawasaki Y, Yuuki H, Kato K, Kurachi M: Characteristics of memory strategy and prefrontal brain volume in schizophrenia spectrum disorders.(優秀演題賞)37th Annual Meeting of International Neuropsychological Society, 2009,2.11-15, Atlanta.
Sumiyoshi T., Higuchi Y., Itoh T., Matsui M., Arai H., Suzuki M., Sumiyoshi C., Kawasaki Y.: Effect of perospironeon P300 electrophysiological activity and social cognition in schizophrenia: A three-dimensional analysis with sLORETA. 17th European Congress of Psychiatry, 2009, 1.24-28, Lisbon, Portugal
Watanabe K, Matsui M, Yoshimura N, Hirono K, Ichida F, Ohshima Y, Matsuzaki T, Yagihara T: Impaired neuroanatomic development in infants with congenital heart disease. 5th World Congress of Pediatric Cardiology and Cardiac Surgery. 2009, 6.22, Cairns, Australia
Sumiyoshi T., Higuchi Y., Matsui M., Itoh H, Itoh T., Arai H, Takamiya C. Uehara T., Suzuki M., Kurachi M.: Membrane fatty acid levels as a predictor of treatment response in schizophrenia. 22nd European Congress of Neuropsychopharmacology, 2009, 6.14, Istanbul, Turkey.
Matsui M, Arai H, Nakatsubo T, Yonezawa M, Sumiyoshi T, Suzuki M, Kurachi M: The effect of cognitive rehabilitation using car driving simulator in schizophrenia. 2009 Mid-Year Meeting of International Neuropsychological Society,2009,7.29-8.1, Helsinki, Finland and Tallinn, Estonia
Shibata T, Matsui M, Kobayashi S, Chan RC, Shibata T: Study of neurological soft sighs in Japanese patients with schizophrenia. 2009 Mid-Year Meeting of International Neuropsychological Society,2009,7.29-8.1, Helsinki, Finland and Tallinn, Estonia
Sumiyoshi T., Higuchi Y., Itoh T., Matsui M., Arai H., Suzuki M., Sumiyoshi C., Kawasaki Y.: Effect of perospirone on P300 electrophysiological activity and social cognition in schizophrenia: A three-dimensional analysis with sLORETA. World Federation of Societies of Biological Psychiatry – The 9th World Congress of Biological Psychiatry, 2009, 7.1, Paris.
Sumiyoshi T., Higuchi Y., Matsui M., Itoh H, Itoh T., Arai H, Takamiya C. Uehara T., Suzuki M., Kurachi M.: Membrane fatty acid levels as a predictor of treatment response in schizophrenia. 1st Asian Congress of Neuropsychopharmacology, 2009, 11.14, Kyoto.
Kawasaki Y, Suzuki M, Sumiyoshi T, Takahashi T, Nishiyama S, Matsui M, Kurachi M, Kazukawa S: Early detection and intervention project for young people at risk of developing psychosis in Toyama. 4th Annual Meeting of Japanese Society f Schizophrenia Research, 2009, 1.30-31, Osaka.
Sumiyoshi T., Higuchi Y., Itoh T., Matsui M., Arai H., Suzuki M., Kurachi M., Sumiyoshi C., Kawasaki Y.: Effect of perospironeon sLORETA images of P300 and social cognition in schizophrenia. 第31回日本生物学的精神医学会、2009, 4, 25, 京都